Author | Santos, Helena Lucia Carneiro | |
Author | Rebello, Karina M. | |
Access date | 2022-08-18T14:27:09Z | |
Available date | 2022-08-18T14:27:09Z | |
Document date | 2022 | |
Citation | SANTOS, Helena Lucia Carneiro; REBELLO, Karina M. An Overview of Mucosa- Associated Protozoa: Challenges in Chemotherapy and Future Perspectives. Frontiers in Cellular and Infection Microbiology. v. 12, Article 860442, p. 1 - 15, Apr. 2022. | pt_BR |
ISSN | 2235-2988 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/54709 | |
Language | eng | pt_BR |
Publisher | Frontiers Media | pt_BR |
Rights | open access | pt_BR |
Subject in Portuguese | Entamoeba histolytica | pt_BR |
Subject in Portuguese | Giardia lamblia | pt_BR |
Subject in Portuguese | Cryptosporidium spp. | pt_BR |
Subject in Portuguese | Trichomonas vaginalis | pt_BR |
Subject in Portuguese | Reinfecção | pt_BR |
Subject in Portuguese | Refratário ao tratamento | pt_BR |
Subject in Portuguese | Droga reaproveitada | pt_BR |
Title | An Overview of Mucosa- Associated Protozoa: Challenges in Chemotherapy and Future Perspectives | pt_BR |
Type | Article | pt_BR |
DOI | 10.3389/fcimb.2022.860442 | |
Abstract | Parasitic infections caused by protozoans that infect the mucosal surfaces are widely
neglected worldwide. Collectively, Entamoeba histolytica, Giardia lamblia,
Cryptosporidium spp. and Trichomonas vaginalis infect more than a billion people in
the world, being a public health problem mainly in developing countries. However, the
exact incidence and prevalence data depend on the population examined. These
parasites ultimately cause pathologies that culminate in liver abscesses, malabsorption
syndrome, vaginitis, and urethritis, respectively. Despite this, the antimicrobial agents
currently used to treat these diseases are limited and often associated with adverse side
effects and refractory cases due to the development of resistant parasites. The paucity of
drug treatments, absence of vaccines and increasing problems of drug resistance are
major concerns for their control and eradication. Herein, potential candidates are reviewed
with the overall aim of determining the knowledge gaps and suggest future perspectives
for research. This review focuses on this public health problem and focuses on the
progress of drug repositioning as a potential strategy for the treatment of
mucosal parasites. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Estudos Integrados em Protozoologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Estudos Integrados em Protozoologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
Subject | Entamoeba histolytica | pt_BR |
Subject | Giardia lamblia | pt_BR |
Subject | Cryptosporidium spp. | pt_BR |
Subject | Trichomonas vaginalis | pt_BR |
Subject | Reinfection | pt_BR |
Subject | Treatment-refractory | pt_BR |
Subject | Repurposed drug | pt_BR |